Clinical Calculator Based on Molecular and Clinicopathologic Characteristics Predicts Recurrence Following Resection...

Area of Science:

• Oncology
• Genomics
• Cancer Research

Background:

• Clinical calculators enhance patient outcome prediction in oncology.
• The American Joint Committee on Cancer (AJCC) endorses calculators for individualized cancer staging.
• Accurate prediction of recurrence is crucial for managing stage I-III colon cancer.

Purpose of the Study:

• To develop and validate a third-generation clinical calculator for predicting recurrence in stage I-III colon cancer.
• To improve the accuracy of patient outcome estimation by incorporating novel molecular and clinicopathologic variables.

Main Methods:

• A prospective cohort of 1,095 patients undergoing colectomy was used for calculator development.
• The calculator was validated externally using a separate patient cohort.
• Discrimination was assessed using the concordance index and calibration curves.

Main Results:

• The calculator integrated six variables: microsatellite genomic phenotype, AJCC T category, lymph node involvement, high-risk pathologic features, tumor-infiltrating lymphocytes, and adjuvant chemotherapy.
• Achieved a concordance index of 0.792, outperforming AJCC 5th (0.708) and 8th (0.757) editions.
• External validation demonstrated robust performance with a concordance index of 0.738.

Conclusions:

• The third-generation calculator accurately predicts colon cancer recurrence, incorporating microsatellite genomic phenotype and tumor-infiltrating lymphocytes.
• This calculator represents an advancement in oncologic tools, demonstrating the value of integrating emerging validated variables.
• Improved predictive accuracy aids in personalized treatment strategies for colon cancer patients.